COPD: Who does, and does not, benefit from triple therapy?

Pierre Ernst, Canada

Professor of Medicine
Faculty of Medicine
McGill University


At the conclusion of this session, participants will be able to:

  • Adopt current COPD treatment guidelines
  • Recognize specific phenotypes of COPD in order to choose the preferred treatment options in different patients
  • Recognise the potential benefit and adverse outcomes associated with the ICS component of Triple Therapy in COPD
  • Become comfortable with the new triple combination inhalers being promoted for the treatment of COPD

Questions Submitted

There are no questions yet...

If you have any questions, please consult our Help Desk.
© 2023 McGill Family Physician Refresher Course